Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3884535 | 0.92 | HDAC6 (0.40) | HDAC6HDAC1HDAC2CA14CA12 | |
| SCHEMBL5555258 | 0.90 | HDAC6 (0.57) | HDAC6HDAC1HDAC2CA14CA12 | |
| SCHEMBL8806268 | 0.87 | HDAC6 (0.41) | HDAC6HDAC1HDAC2CA14CA12 | |
| SCHEMBL4676227 | 0.87 | HDAC6 (0.46) | HDAC6HDAC1HDAC2CA14NFKB1 | |
| SCHEMBL27765894 | 0.87 | HDAC6 (0.46) | HDAC6HDAC1HDAC2CA14CA12 | |
| SCHEMBL5943153 | 0.84 | HDAC6 (0.51) | HDAC6HDAC1HDAC2CA14NFKB1 | |
| SCHEMBL8896065 | 0.84 | HDAC6 (0.51) | HDAC6HDAC1HDAC2CA14NFKB1 | |
| SCHEMBL1706932 | 0.84 | HDAC6 (0.38) | HDAC6HDAC1HDAC2CA14CA12 | |
| SCHEMBL5580137 | 0.83 | AKT1 (0.39) | HDAC6HDAC1HDAC2CA14CA12 | |
| SCHEMBL1401436 | 0.83 | AKT1 (0.39) | HDAC6HDAC1HDAC2CA14CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1183049-B1 | MODIFICATION OF BIOLOGICAL ELEMENTS | HYBRID SYSTEMS LTD (GB) | 2009-01-14 | — | — | EP | disclosed |
| US-7279318-B1 | Modification of biological elements | HYBRID SYSTEMS LIMITED (GB) | 2007-10-09 | — | — | US | disclosed |
| EP-0941123-B1 | NUCLEIC ACID COMPLEXED WITH CATIONIC POLYMER USEFUL FOR GENE THERAPY | HYBRID SYSTEMS LTD (GB) | 2002-06-12 | — | — | EP | disclosed |
| EP-1183049-A2 | MODIFICATION OF BIOLOGICAL ELEMENTS | Hybrid Systems Limited (GB) | 2002-03-06 | — | — | EP | disclosed |
| US-6312727-B1 | SYNTHETIC POLYMER CARRIER VEHICLE FOR DELIVERY OF NUCLEIC ACID TO TARGET CELLS IN BIOLOGICAL SYSTEMS | HYBRID SYSTEMS LIMITED (GB) | 2001-11-06 | — | — | US | disclosed |
| WO-2000074722-A2 | MODIFICATION OF BIOLOGICAL ELEMENTS | HYBRID SYSTEMS LIMITED (GB) | 2000-12-14 | — | — | WO | disclosed |
| EP-0941123-A2 | DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS | SCHACHT, Etienne Honoré (BE) | 1999-09-15 | — | — | EP | disclosed |
| WO-1998019710-A2 | DELIVERY OF NUCLEIC ACID MATERIAL TO TARGET CELLS IN BIOLOGICAL SYSTEMS | SCHACHT ETIENNE HONORE (BE) | 1998-05-14 | — | — | WO | disclosed |